drugset / Trial / NCT06556511

Efficacy Of Zinc Towards The Outcome on Children With Sepsis

NCT06556511

RandomizedParallel-groupOpen-labelOther

Summary

Sepsis is a life-threatening organ failure induced by a compromised immune response to infection. Sepsis is a leading cause of morbidity and mortality (50-60%) in children treated in inpatient and critical care units. Children suffering from immunodeficiency have a higher mortality rate. Several studies in recent years have revealed that zinc homeostasis may be a significant role in the prevention of sepsis. It was important to conduct this study to determine the efficacy of zinc in children suffering from sepsis.

Timeline

Start
2024-02-01
Primary completion
2024-05-31
Completion
2024-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Zinc Sulfate Unknown 10 mg
Subject Zinc Sulfate Unknown 20 mg